Liminatus Pharma secures $1.9M via warrant exercises
Liminatus Pharma has entered into a warrant exercise agreement to raise $1.9M.
The company will issue new unregistered warrants to purchase 20.68M shares.
The agreement involves the exercise of outstanding warrants for 10.34M shares.